Nevertheless, HO-1 lacks a DNA binding domain and whether it can interact with transcriptional control factors or chromatin proteins to impact the expression of specific genes related to cancer progression is still a matter of debate and deserves further investigation (141). The gene discussed is HMOX1; the disease is cancer.